Shufeng Jiedu capsules for treating acute exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis
Abstract Background Chinese herbal medicine is widely used in combination with usual care for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in China. Chinese patent medicine Shufeng Jiedu (SFJD) capsules is widely used for respiratory infectious diseases. This review aims to...
Saved in:
Main Authors: | Ru-yu Xia (Author), Xiao-yang Hu (Author), Yu-tong Fei (Author), Merlin Willcox (Author), Ling-zi Wen (Author), Ming-kun Yu (Author), Li-shan Zhang (Author), Meng-yuan Dai (Author), Guang-he Fei (Author), Mike Thomas (Author), Nick Francis (Author), Tom Wilkinson (Author), Michael Moore (Author), Jian-ping Liu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
by: Xiao-Wen Zhang, et al.
Published: (2022) -
A synthesis of the evidence regarding safety of a Chinese herbal formula Shufeng Jiedu: A pharmacological review
by: Jeanne Trill, et al.
Published: (2022) -
Study on basic and clinical application of Shufeng Jiedu Capsule in treating respiratory tract infection
by: Yanqi Han, et al.
Published: (2023) -
Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial
by: Chun-li Lu, et al.
Published: (2024) -
Huangkui Capsule Ameliorates Renal Fibrosis in a Unilateral Ureteral Obstruction Mouse Model Through TRPC6 Dependent Signaling Pathways
by: Li-fei Gu, et al.
Published: (2020)